Supply chain gaps and the uncontrolled rise of informal drug markets are driving Kenya's illegal pharmaceutical trade, which poses serious risks to public health and the economy.
A paper by CFAO Healthcare and the OPALS Foundation titled Securing the Medicine Distribution Network in Africa, discovered that one in three medicines in Africa, including Kenya, may be counterfeit, resulting in a combined annual loss of €500 million (Sh74.55billion) in unpaid taxes.
